Oracle Corporation (ORCL) research: valuation against peers, fundamentals over time, risk and news coverage

ORCL

Oracle Corporation
USD
135.69
-5.48% today
Market cap
—
P/E trailing
—
P/E forward
—
EV/EBITDA
—
Op margin
—
Rev growth
—
Div yield
—
Beta
—
52-week range114.99 – 313.008 report(s) in our archive
Price navigator — ORCL

No data in this window.

    INDY NEWS coverage of ORCL8

    Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.

    Full archive search for ORCL

    Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.

    Guidance reliability · ORCLmethodology·all companies

    Only 1 resolved quarter on record — below the 6-period threshold, so no verdict is published.

    n = 1 resolved forecast · Q4 FY2026 to Q4 FY2026 · 4 still outstanding

    Insufficient sample — no verdict published. ORCL has 1 resolved forecast on record, below the 6 needed before we will characterise a management team’s forecasting. The record below is published in full; the company is excluded from every ranking on this site until it clears the threshold.

    Pattern
    Not enough resolved periods
    1 resolved
    Avg. signed deviation
    +5.6%
    outside its own range
    Avg. vs midpoint
    +6.6%
    where in the range it lands
    Avg. range width
    2.0%
    room it leaves itself
    Above guidance1

    Next report expected 08 Dec 2026 (Q1 FY2027) — Estimated from the issuer's own filing history: FY2026Q1 results were released on 2025-09-09. source

    The record — 6 forecasts, 5 scoredevery figure sourced
    Every forecast ORCL management issued in its own earnings releases, with the outcome the company later reported and a link to both source documents.
    PeriodMeasureGuidedIssuedReportedLandedDeviationVerdictSources
    Q1 FY2027EPS (adj.)$1.72–$1.762026-06-10———PENDINGguidance
    “Non-GAAP earnings per share is expected to grow between 16% and 19% and be between $1.71 and $1.75 in constant currency and grow between 17% and 20% and be between $1.72 and $1.76 in USD.”
    FY 2027EPS (adj.)$8.052026-06-10———PENDINGguidance
    “For fiscal year 2027, we confirm our prior revenue guidance of $90 billion total revenue and raise our non-GAAP EPS guidance to $8.05, which is growth of 18%1 after adjusting for the one-time events of selling our Ampere chip business and Bloom Energy warrants in fiscal year 2026.”
    FY 2027revisedRevenue$90.0bn2026-06-10———PENDINGguidance
    “For fiscal year 2027, we confirm our prior revenue guidance of $90 billion total revenue and raise our non-GAAP EPS guidance to $8.05, which is growth of 18%1 after adjusting for the one-time events of selling our Ampere chip business and Bloom Energy warrants in fiscal year 2026.”
    FY 2027Revenue$90.0bn2026-03-10———PENDINGguidance
    “For fiscal year 2027, we are raising total revenue guidance to $90 billion.”
    Q4 FY2026EPS (adj.)$1.96–$2.002026-03-10$2.11+5.6%ABOVEguidance · result
    “Non-GAAP earnings per share is expected to grow between 15% to 17% and be between $1.92 and $1.96 in constant currency and grow between 15% to 17% and be between $1.96 and $2.00 in USD.”
    FY 2026Revenue$67.0bn2026-03-10———PENDINGguidance
    “For fiscal year 2026, we expect revenue of $67 billion and capital expenditures of $50 billion.”

    Every figure above is read from the company’s own filings. “Guidance” links to the 8-K exhibit that issued the forecast; “result” links to the exhibit in which the company reported the outcome. Nothing here is an analyst estimate. How this is measured.

    Coverage universe: S&P 100. This is a factual record of what a company forecast and what it then reported. It is not investment advice, and it is not a view on the company’s prospects — we publish the measurement and draw no conclusion from it.